Tafinlar Capsule
Product Images NDC 0078-0682
Product Visual Gallery
This gallery contains 30 technical images submitted to the FDA as part of the official labeling for Tafinlar (NDC 0078-0682). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1. Kaplan-meier Curves Of Investigator-assessed Progression-free Survival In The Break-3 Study (Tafinlar 02)
Figure 2. Kaplan-meier Curves For Overall Survival In The Combi-d Study (Tafinlar 03)
Figure 3. Kaplan-meier Curves For Overall Survival In The Combi-v Study (Tafinlar 04)
Figure 4. Kaplan-meier Curves For Investigator-assessed Relapse-free Survival In Combi-ad In The Adjuvant Treatment Of Melanoma (Tafinlar 07)
Figure 5. Kaplan-meier Curves For Progression-free Survival In Study G2201 (lgg Cohort) (Tafinlar 08)
Tafinlar-ifu-illustrations-1 (Tafinlar 09)
Tafinlar-ifu-illustrations-2 (Tafinlar 10)
Tafinlar-ifu-illustrations-3 (Tafinlar 11)
Tafinlar-ifu-illustrations-4 (Tafinlar 12)
Tafinlar-ifu-illustrations-5 (Tafinlar 13)
Tafinlar-ifu-illustrations-6 (Tafinlar 14)
Tafinlar-ifu-illustrations-7 (Tafinlar 15)
Tafinlar-ifu-illustrations-8 (Tafinlar 16)
Tafinlar-ifu-illustrations-9 (Tafinlar 17)
Tafinlar-ifu-illustrations-10 (Tafinlar 18)
Tafinlar-ifu-illustrations-11 (Tafinlar 19)
Tafinlar-ifu-illustrations-12 (Tafinlar 20)
Tafinlar-ifu-illustrations-13 (Tafinlar 21)
Tafinlar-ifu-illustrations-14 (Tafinlar 22)
Tafinlar-ifu-illustrations-15 (Tafinlar 23)
Tafinlar-ifu-illustrations-16 (Tafinlar 24)
Tafinlar-ifu-illustrations-17 (Tafinlar 25)
Tafinlar-ifu-illustrations-18 (Tafinlar 26)
Tafinlar-ifu-illustrations-19 (Tafinlar 27)
Tafinlar-ifu-illustrations-20 (Tafinlar 28)
Tafinlar-ifu-illustrations-21 (Tafinlar 29)
Principal Display Panel Ndc 0078-0682-66 Tafinlar® (dabrafenib) Capsules 50 mg Rx Only 120 Capsules Dispense With Medication Guide Attached Or Provided Separately. Novartis (Tafinlar 06)
Principal Display Panel Ndc 0078-0681-66 Tafinlar® (dabrafenib) Capsules 75 mg Rx Only 120 Capsules Dispense With Medication Guide Attached Or Provided Separately. Novartis (Tafinlar 05)
Principal Display Panel Ndc 0078-1154-21 Rx Only Tafinlar® (dabrafenib) Tablets For Oral Suspension* 10 mg Per Tablet *disperse Tablets In Water Prior To Ingestion. Do Not Swallow Whole, Chew Or Crush. Dispense And Store In Original Container With The Desiccant**. Dispense With Medication Guide. 210 Tablets Novartis (Tafinlar 30)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.